Alnylam Pharmaceuticals
ALNY
#630
Rank
NZ$70.80 B
Marketcap
NZ$530.34
Share price
0.21%
Change (1 day)
0.27%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company